The CD4-independent tropism of human immunodeficiency virus type 2 involves several regions of the envelope protein and correlates with a reduced activation threshold for envelope-mediated fusion

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1453-1465

  Reeves, Jacqueline D ^a   Schulz, Thomas F ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CELL FUSION; DNA FLANKING REGION; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 2; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; VIRUS ENVELOPE; VIRUS REACTIVATION;

EID: 0031015211     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1453-1465.1997     Document Type: Article

References (81)

1. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-lropic HIV-1. Science 272: 1955-1958.
2. Ashorn, P. A., E. A. Berger, and B. Moss. 1990. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64:2149-2156.
3. Bou-Habib, D. C., G. Roderiguez, T. Oravecz, P. W. Berman, P. Lusso, and M. A. Norcross. 1994. Cryptic nature of envelope V3 region epilopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68:6006-6013.
4. Boyd, M. T., G. R. Simpson, A. J. Cann, M. A. Johnson, and R. A. Weiss. 1993. A single amino acid substitution in the Vl loop of human immunodeficiency virus typo 1 gpl20 alters cellular tropism. J. Virol. 67:3649-3652.
5. Bullough, P. A., F. M. Hughson, J. J. Skehel, and D. C. Wiley. 1994. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371:37-43.
6. Byrn, R. A., J. Mordenti, C. Lucas, D. Smith, S. A. Marsters, J. S. Johnson, P. Cossum, S. M. Charnow, F. M. Wurm, T. Gregory, et al. 1990. Biological properties of a CD4 immunoadhesin. Nature 344:667-670.
7. Carr, C. M., and P. S. Kim. 1993. A spring-loaded mechanism for the contormational change of influenza haemagglutinin. Cell 73:823-832.
8. Chen, C.-H., T. J. Matthews, C. B. McDanal, U. Bolognesi, and M. L. Greenberg. 1995. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication tor viral fusion. J. Virol. 69:3771-3777.
9. Chiodi, F., S. Fuerstenberg, M. Gidlund, B. Asjo, and E. M. Fenyo. 1987. Infection of brain-derived cells wilh the human immunodeficiency virus. J. Virol. 61:1244-1247.
10. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The B-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
11. Choe, H.-R., and J. Sodroski. 1995. Adaptation of human immunodeficiency virus type 1 to cells expressing a binding-deficient CD4 mutant (lysine 46 to aspartic acid). J. Virol. 69:2801-2810.
12. Clapham, P. R., J. N. Weber, D. Whitby, K. Mclntosh, A. G. Dalgleish, P. J. Maddon, K. C. Deen, R. W. Sweet, and R. A. Weiss. 1989. Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T-cells and monocytes but not for brain and muscle cells. Nature 337:368-370.
13. Clapham, P. R., D. Blanc, and R. A. Weiss. 1991. Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1. type 2 and simian immunodeficiency virus. Virology 181:703-715.
14. Clapham, P. R., A. McKnight, and R. A. Weiss. 1992. Human immunodeficiency virus type 2 infection and fusion of CD4 negative cell lines: induction and enhancement by soluble CD4. J. Virol. 6:3531-3537.
15. Connor, R. L, and D. D. Ho. 1994. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
16. Cordonnier, A., L. Montagnier, and M. Emerman. 1989. Single amino acid changes in HIV envelope affect viral tropism and receptor binding. Nature 340:571-574.
17. Curtis, B. M., S. Scharnowske, and A. J. Watson. 1992. Sequence and expression of membrane-associated C-type lectin that exhibits CD4-independcnt binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89:8356-8360.
18. Daar. E., X. L. Li, T. Moudgil, and D. D. Ho. 1990. High concentrations of recombinant soluble CD4 arc required to neutralize primary human immunodeficiency virus type 1 isolates. Proc. Natl. Acad. Sci. USA 87:6574-6578.
19. Daniels, R. S., J. C. Downie, J. A. Hay, M. Knossow, J. J. Skehel, M. L. Wang, and D. C. Wiley. 1985. Fusion mulanls of the influenza virus hemagglutinin glycoprotein. Cell 40:431-439.
20. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Liftman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666.
21. Dcwhurst, S., K. Sakai, J. Bresser, M. Stevenson, M. J. Evinger-Hodges, and D. J. Volsky. 1987. Persistent productive infection of human glial cells by human immunodeficiency virus (HlV) and by infectious molecular clones of HIV. J. Virol. 61:3774-3782.
22. Doranz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HlV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion co-factors. Cell 85:1149-1158.
23. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381:667-673.
24. Dubay, J. W., S. J. Roberts, B. Brody, and E. Hunter. 1992. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmbrane glycoprotein affect fusion and intectivity. J. Virol. 66:4748-1756.
25. Dukes, C. S., Y. Yu, E. D. Rivadeneira, D. L. Sauls, H. X. Liao, B. F. Haynes, and J. B. Weinberg. 1995. Cellular CD44S as a determinant of human immunodeficiency virus type 1 infection and cellular tropism. J. Virol. 69: 4000-4005.
26. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein - coupled receptor. Science 272:872-877.
27. Fenyö. E. M., L. Morfeldt-Manson, F. Chiodi, et al. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
28. Gallaher, W. R., J. M. Ball, R. F. Carry, M. C. Griffin, and R. C. Montelaro. 1989. A general model for the transmembrane proteins of HlV and other retroviruses. AIDS Res. Hum. Retroviruses 5:431-440.
29. Gilljam, G. 1993. Envelope glycoproteins of HIV-1. HIV-2, and SIV purified with Galanthus nivalis agglutinin induce strong immune responses. AIDS. Res. Hum. Retroviruses. 9:431-438.
30. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature 326:662-669.
31. Harouse, J. M., C. Kunsch, H. T. Harlte, M. A. Laughlin, J. A. Hoxie, B. Wigdahl, and F. Gonzalez-Scarano. 1989. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J. Virol. 63: 2527-2533.
32. Harouse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silberberg, and F. Gonzalez-Scarano. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320-323.
33. Harouse, J. M., R. C. Collman, and F. González-Scarano. 1995. Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3′ sulfo-galactosyl ceramide-positive cell line. J. Virol. 69:7383-7390.
34. Healey, D., L. Dianda, J. P. Moore, J. S. McDougal, M. J. Moore, P. Estess, D. Buck, P. D. Kwong, P. C. Beverley, and Q. J. Sattentau. 1990. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding. J. Exp. Med. 172: 1233-1242.
35. Helseth, E., U. Olshevsky, C. Furman, and J. Sodroski. 1991. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. J. Virol. 65:2119-2123.
36. Hirsch, V. M., P. Edmondson, M. Murphy-Corb, B. Arbeille, P. R. Johnson, and J. I. Mullins. 1989. SIV adaptation to human cells. Nature 341:573-574.
37. 36a.Hoxie, J. A. 1996. Personal communication.
38. Hoxie, J. A., L. F. Brass, C. H. Pletcher, B. S. Haggarty, and B. H. Hahn. 1991. Cytopathic variants of an attenuated isolate of human immunodeficiency virus type 2 exhibit increased affinity for CD4. J. Virol. 65:5096-5101.
39. Hwang, S. R., T. J. Boyle, K. Lyerle, and B. R. Cullen. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74.
40. Rabat, D., S. L. Kozak, K. Wehrly, and B. Chesebro. 1994. Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J. Virol. 68:2570-2577.
41. Keller, R., K. Peden, S. Paulous, L. Montagnier, and A. Cordonnier. 1993. Amino acid changes in the fourth conserved region of human immunodeficiency virus type 2 strain HIV-2ROD envelope glycoprotein modulate fusion. J. Virol. 67:6253-6258.
42. Kent, K. A., E. Rud, T. Corcoran, C. Powell, C. Thiriart, C. Collignon, and E. J. Stott. 1992. Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8:1147-1151.
43. Kong, L. I., S.-W. Lee, J. C. Kappes, J. S. Parkin, D. Decker, J. A. Hoxie, B. H. Hahn, and G. M. Shaw. 1988. West African HIV-2 related human retrovirus with attenuated cytopathicity. Science 240:1525-1528.
44. LaBranche, C. C., M. M. Sauter, B. S. Haggarty, P. J. Vance, J. Romano, T. K. Hart, P. J. Bugelski, and J. A. Hoxie. 1994. Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus. J. Virol. 68:5509-5522.
45. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and brain. Cell 47:333-348.
46. Matthews, T. J. 1994. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses 10:631-632.
47. McKnight, A., P. R. Clapham, and R. A. Weiss. 1994. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 201:8-18.
48. McKnight, A., C. Shotton, J. Cordell, I. Jones, G. Simmons, and P. R. Clapham. 1996. Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein. J. Virol. 70:4598-4606.
49. Moore, J. P. 1995. Back to primary school. Nature 376:115.
50. Moore, J. P., L. A. Wallace, E. A. C. Follet, and J. A. McKeating. 1989. An enzyme-linked immunosorbent assay for antibodies to the envelope glycoproteins of divergent strains of HIV-1. AIDS 3:155-163.
51. Moore, J. P., J. A. McKeating, R. A. Weiss, and Q. A. Sattentau. 1990. Dissociation of gp120 from HIV-1 virions induced by soluble CD4. Science 250:1139-1142.
52. Moore, J. P., Y. Morikawa, and I. M. Jones. 1991. Binding of recombinant HIV-1 and HIV-2 SU glycoproteins to sCD4. AIDS Res. Hum. Retroviruses 4:442-449.
53. Moore, J. P., J. A. McKeating, Y. Huang, A. Ashkenasi, and D. D. Ho. 1992. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4 sensitive isolates. J. Virol. 66:235-243.
54. Moore, J. P., M. Thali, B. A. Jameson, F. Vignaux, G. K. Lewis, S.-W. Poon, M. S. Fung, P. J. Durda, L. Akerblom, B. Wahren, D. D. Ho, Q. J. Sattentau, and J. Sodroski. 1993. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:4785-4796.
55. Morrison, H., F. Kirchhoff, and R. Desrosiers. 1993. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry. Virology 195:167-174.
56. Mulligan, M. J., G. V. Yamshchikov, G. D. Ritter, F. Gao, M. J. Jin, C. D. Nail, C. P. Spies, B. H. Hahn, and R. W. Compans. 1992. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:3971-3975.
57. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
58. Oravecz, T., G. Roderiquez, J. Koffi, J. Wang, M. Ditto, D. C. Bou-Habib, P. Lusso, and M. A. Norcross. 1995. CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nat. Med. 1:919-927.
59. Ploegh, H. L., L. E. Cannon, and J. L. Strominger. 1979. Cell tree translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens. Proc. Natl. Acad. Sci. USA 76:2273-2276.
60. Reeves, J. D., et al. Unpublished data.
61. Rey, M. A., B. Spire, D. Dormont, F. Barré-Sinoussi, L. Monagnier, and J. C. Chermann. 1984. Characterisation of the RNA-dependent DNA polymerase of a new human T lymphotropic retrovirus (lymphadenopathy associated virus). Biochem. Biophys. Res. Commun. 121:126-133.
62. Sattentau, Q. J. and J. P. Moore. 1991. Conformational changes in the human immunodeficiency virus envelope glycoproteins by soluble CD4 binding. J. Exp. Med. 174:407-415.
63. Sattentau, Q. J., and R. A. Weiss. 1988. The CD4 antigen: physiological ligand and HIV receptor. Cell 52:631-633.
64. Schuitemaker, H., N. A. Kootstra, R. E. de Goede, F. de Wolf, F. Miedema, and M. Tersmette. 1991. Monocytotropic human immunodeficiency virus type 1 (HIV-1) variants detectable in all stages of HIV-1 infection lack T-cell line tropism and syncytium-inducing ability in primary T-cell culture. J. Virol. 65:356-363.
65. Schulz, T. F., D. Whitby, J. G. Hoad, T. Corrah, H. Whittle, and R. A. Weiss. 1990. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J. Virol. 64:5177-5182.
66. Schutten, M., A. C. Andeweg, M. L. Bosch, and A. D. M. E. Osterhaus. 1995. Enhancement of infectivity of a non-syncytium inducing HIV-1 by sCD4 and by human antibodies that neutralize syncytium-inducing HIV-1. Scand. J. Immunol. 41:18-22.
67. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 349:167-169.
68. Smith, S. D., M. Shatsky, P. S. Cohen, R. Waruke, M. P. Link, and B. E. Glader. 1984. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 44:5657-5660.
69. Stamatatos, L., and C. Cheng-Mayer. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67:5635-5639.
70. Stamatatos, L., and C. Cheng-Mayer. 1995. Structural modulations of the envelope gp120 glycoprotein of human immunodeficiency virus type 1 upon oligomerization and differential V3 loop exposure of isolates displaying distinct tropism upon virion-soluble receptor binding. J. Virol. 69:6191-6198.
71. Stratton, M. R., B. R. Reeves, and C. S. Cooper. 1989. Misidentified cell. Nature 337:311-312.
72. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
73. Takeuchi, Y., M. Akutsu, K. Murayama, N. Shimuzu, and H. Hoshino. 1991. Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J. Virol. 65:1710-1718.
74. Talbot, S. J., R. A. Weiss, and T. F. Schulz. 1995. Reduced glycosylation of human cell lines increases susceptibility to CD4-independent infection by human immunodeficiency virus type 2 (LAV2/B). J. Virol. 69:3399-3406.
75. Tatento, M., F. Gonzalez-Scareno, and J. A. Levy. 1989. Human immunodeficiency virus can infect CD4-negative human fibroblastoid cell. Proc. Natl. Acad. Sci. USA 86:4287-4292.
76. Tersmette, M., J. M. Lange, R. E. de Goede, et al. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i:983-985.
77. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-108. In J. A. Levy (ed.), The Retroviridae, vol. 1. Plenum Press, New York, N.Y.
78. Westervelt, P., D. N. Trowbridge, L. G. Epstein, B. M. Blumberg, Y. Li, B. H. Hahn, G. M. Shaw, R. W. Price, and L. Ratner. 1992. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:2577-2582.
79. Wild, C., T. Oas, C. McDanal, D. Bolognesi, and T. Matthews. 1992. A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition. Proc. Natl. Acad. Sci. USA 89:10537-10541.
80. Wyatt, R., M. Thali, S. Tilley, A. Pinter, M. Posner, D. Ho, J. Robinson, and J. Sodroski. 1992. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. J. Virol. 66:6997-7004.
81. Zingler, K., and D. R. Littman. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and infectivity. J. Virol. 67:2824-2831.